Inventor · disambiguated record
Mitsuru Naiki
Also filed as: NAIKI MITSURU
18 granted patents·9 pending applications·35 citations·filing 1992–2023
90Inventor score
Files withNIPPON ZOKI PHARMACEUTICAL CO11UNIV OSAKA4IINUMA MUNEKAZU3TOKAI UNIV EDUCATIONAL SYSTEM2MASUDA KOICHI1
Top patents by PatentIndex Score
27 records- 0180US12029751B2Therapeutic agent for nervous system diseaseUNIV OSAKA·Filed 2023·Granted Jul 9, 2024·0 cites·4 claims
- 0276US12252824B2Nonwoven fabric, method for manufacturing same, and composition for electrospinningNAT INST MATERIALS SCIENCE·Filed 2019·Granted Mar 18, 2025·2 cites·12 claims
- 0375US11679122B2Therapeutic agent for nervous system diseaseUNIV OSAKA·Filed 2022·Granted Jun 20, 2023·0 cites·5 claims
- 0475US9428477B2Trans-2-decenoic acid derivative and drug containing sameNIPPON ZOKI PHARMACEUTICAL CO·Filed 2013·Granted Aug 30, 2016·3 cites·8 claims
- 0569US8987486B2Trans-2-decenoic acid derivative and pharmaceutical agent containing the sameIINUMA MUNEKAZU·Filed 2011·Granted Mar 24, 2015·2 cites·23 claims
- 0666US11369626B2Therapeutic agent for nervous system diseaseUNIV OSAKA·Filed 2020·Granted Jun 28, 2022·0 cites·7 claims
- 0759US2022079995A1Agent for promoting expression of n-acetylgalactosaminyltransferase containing extract from inflamed tissues inoculated with vaccinia virusTOKAI UNIV EDUCATIONAL SYSTEM·Filed 2021·Application pending·0 cites
- 0858US12473664B2Medical sheetNIPPON ZOKI PHARMACEUTICAL CO·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 0956US10711292B2Method for promoting the synthesis of collagen and proteoglycan in chondrocytesNIPPON ZOKI PHARMACEUTICAL CO·Filed 2015·Granted Jul 14, 2020·0 cites·1 claims
- 1054US2019255121A1Agent for promoting expression of n-acetylgalactosaminyltransferase containing extract from inflamed tissues inoculated with vaccinia virusTOKAI UNIV EDUCATIONAL SYSTEM·Filed 2019·Application pending·0 cites
- 1151US6251929B1Therapeutic agent for intractable vasculitisNIPPON ZOKI PHARMACEUTICALS CO·Filed 1999·Granted Jun 26, 2001·13 cites·20 claims
- 1248US9557327B2DNA controlling miR-140 expression, and screening method of drugs using said DNANAT CENTER FOR CHILD HEALTH AND DEV·Filed 2013·Granted Jan 31, 2017·0 cites·17 claims
- 1347US11129976B2Test methodUNIV OSAKA·Filed 2017·Granted Sep 28, 2021·0 cites·6 claims
- 1447US2010048408A1Method for study, determination or evaluation by gene expression analysisNIPPON ZOKI PHARMACEUTICAL CO·Filed 2007·Application pending·0 cites
- 1546US2014255507A9Method for promoting the synthesis of collagen and proteoglycan in chondrocytesMASUDA KOICHI·Filed 2011·Application pending·0 cites
- 1645US2005245577A1Drug for kidney failure containing oxaluric acid derivativeNAIKI MITSURU·Filed 2003·Application pending·0 cites
- 1744US9365533B2Coumarin derivativeNIPPON ZOKI PHARMACEUTICAL CO·Filed 2013·Granted Jun 14, 2016·0 cites·19 claims
- 1842US6238665B1Anti-edema agentNIPPON ZOKI PHARMACEUTICAL CO·Filed 1999·Granted May 29, 2001·4 cites·20 claims
- 1942US5376682AFuranone derivatives for the treatment of inflammationNIPPON ZOKI PHARMACEUTICAL CO·Filed 1992·Granted Dec 27, 1994·10 cites·5 claims
- 2039US10780133B2Method for protecting liver and a liver protecting agentUNIV CALIFORNIA·Filed 2015·Granted Sep 22, 2020·0 cites·21 claims
- 2139US2006241162A1Optically active (R)-hydantoin derivativeOKAMOTO KAORU·Filed 2005·Application pending·0 cites
- 2239US2015297562A1AnalgesicNIPPON ZOKI PHARMACEUTICAL CO·Filed 2013·Application pending·0 cites
- 2335US2013296425A1Prophylactic or therapeutic agent for a peripheral nerve disorder induced by anti-cancer agentsIINUMA MUNEKAZU·Filed 2012·Application pending·0 cites
- 2435US2013296426A1AnalgesicIINUMA MUNEKAZU·Filed 2012·Application pending·0 cites
- 2533US10004716B2Therapeutic/ preventive agent containing coumarin derivative as active ingredientNIPPON ZOKI PHARMACEUTICAL CO·Filed 2015·Granted Jun 26, 2018·0 cites·13 claims
- 2626US6627194B1Activated immunoglobulinNIPPON ZOKI PHARMACEUTICAL CO·Filed 1996·Granted Sep 30, 2003·0 cites·23 claims
- 2726US5532271AFuranone derivatives for the suppression or treatment of autoimmune diseasesNIPPON ZOKI PHARMACEUTICAL CO·Filed 1994·Granted Jul 2, 1996·1 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →